Atrium Ljungberg AB (OSTO:ATRLJ B, Financial) is set to release its Q3 2024 earnings on October 11, 2024. The consensus estimate for Q3 2024 revenue is $729.67 million, and the earnings are expected to come in at $0.71 per share. The full year 2024's revenue is expected to be $3.05 billion and the earnings are expected to be $7.86 per share. More detailed estimate data can be found on the Forecast page.
Atrium Ljungberg AB (OSTO:ATRLJ B, Financial) Estimates Trends
Over the past 90 days, revenue estimates for Atrium Ljungberg AB (OSTO:ATRLJ B) have declined from $3.07 billion to $3.05 billion for the full year 2024, and from $3.14 billion to $3.09 billion for 2025. Earnings estimates have also been revised downward from $8.22 per share to $7.86 per share for the full year 2024, and from $12.01 per share to $11.59 per share for 2025.
Atrium Ljungberg AB (OSTO:ATRLJ B, Financial) Reported History
In the previous quarter of June 30, 2024, Atrium Ljungberg AB's (OSTO:ATRLJ B) actual revenue was $753 million, which missed analysts' revenue expectations of $783.98 million by -3.95%. Atrium Ljungberg AB's (OSTO:ATRLJ B) actual earnings were $2.03 per share, which beat analysts' earnings expectations of -$0.955 per share by 312.57%. After releasing the results, Atrium Ljungberg AB (OSTO:ATRLJ B) was up by 6% in one day.
Atrium Ljungberg AB (OSTO:ATRLJ B, Financial) 12 Month Price Targets
Based on the one-year price targets offered by 6 analysts, the average target price for Atrium Ljungberg AB (OSTO:ATRLJ B) is $235.17 with a high estimate of $275 and a low estimate of $210. The average target implies a downside of -0.77% from the current price of $237.
Based on GuruFocus estimates, the estimated GF Value for Atrium Ljungberg AB (OSTO:ATRLJ B, Financial) in one year is $195.18, suggesting a downside of -17.65% from the current price of $237.
Based on the consensus recommendation from 7 brokerage firms, Atrium Ljungberg AB's (OSTO:ATRLJ B, Financial) average brokerage recommendation is currently 3.4, indicating a "Hold" status. The rating scale ranges from 1 to 5, where 1 signifies a strong buy, and 5 denotes a sell.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
